Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Milestone Pharmaceuticals aggregated by PharmaCompass.com.

    Client Virtual Booth

    MILESTONE PHARMACEUTICALS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Milestone Pharmaceuticals
    Canada Flag
    Country
    Country
    Canada
    Address
    Address
    1111 Dr.-Frederik-Philips Blvd., Suite 420 Saint-Laurent, (Quebec) H4M 2X6 Canada
    Telephone
    Telephone
    (514) 336-0444
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://milestonepharma.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Milestone Announces Etripamil Data at The American College of Cardiology Meeting
    Milestone Announces Etripamil Data at The American College of Cardiology Meeting

    https://www.globenewswire.com/news-release/2024/04/08/2859368/0/en/Milestone-Pharmaceuticals-Announces-Etripamil-Data-Demonstrating-Patients-Ability-to-Self-Manage-Recurring-PSVT-Presented-at-The-American-College-of-Cardiology-Annual-Meeting.html

    GLOBENEWSWIRE
    08 Apr 2024
    Share Share
    Milestone Pharma to Present at the 23rd Annual Needham Healthcare Conference
    Milestone Pharma to Present at the 23rd Annual Needham Healthcare Conference

    https://www.globenewswire.com/news-release/2024/04/03/2856874/0/en/Milestone-Pharmaceuticals-to-Present-at-the-23rd-Annual-Needham-Healthcare-Conference.html

    GLOBENEWSWIRE
    03 Apr 2024
    Share Share
    Milestone to Present Data on Etripamil at the Association Annual Conferences
    Milestone to Present Data on Etripamil at the Association Annual Conferences

    https://www.globenewswire.com/news-release/2024/04/01/2855135/0/en/Milestone-Pharmaceuticals-to-Present-Data-on-Etripamil-at-the-American-College-of-Cardiology-and-European-Heart-Rhythm-Association-Annual-Conferences.html

    GLOBENEWSWIRE
    01 Apr 2024
    Share Share
    Milestone Announces Resubmission of NDA for Etripamil for Treatment in PST
    Milestone Announces Resubmission of NDA for Etripamil for Treatment in PST

    https://www.globenewswire.com/news-release/2024/03/28/2853852/0/en/Milestone-Pharmaceuticals-Announces-Resubmission-of-New-Drug-Application-for-Etripamil-for-Treatment-in-Paroxysmal-Supraventricular-Tachycardia.html

    GLOBENEWSWIRE
    28 Mar 2024
    Share Share
    Milestone Reports Fourth Quarter and Full Year 2023 Financial Results
    Milestone Reports Fourth Quarter and Full Year 2023 Financial Results

    https://www.globenewswire.com/news-release/2024/03/21/2850117/0/en/Milestone-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Regulatory-and-Corporate-Update.html

    GLOBENEWSWIRE
    21 Mar 2024
    Share Share
    Milestone Announces Pricing of $30.0 Million Public Offering of Common Shares
    Milestone Announces Pricing of $30.0 Million Public Offering of Common Shares

    https://www.globenewswire.com//news-release/2024/02/29/2837807/0/en/Milestone-Pharmaceuticals-Announces-Pricing-of-30-0-Million-Public-Offering-of-Common-Shares-and-Pre-Funded-Warrants.html

    GLOBENEWSWIRE
    29 Feb 2024
    Share Share
    Milestone® Pharmaceuticals to Participate in a Corporate Panel Discussion
    Milestone® Pharmaceuticals to Participate in a Corporate Panel Discussion

    https://www.globenewswire.com//news-release/2024/02/29/2838370/0/en/Milestone-Pharmaceuticals-to-Participate-in-a-Corporate-Panel-Discussion-at-TD-Cowen-44th-Annual-Health-Care-Conference.html

    GLOBENEWSWIRE
    29 Feb 2024
    Share Share
    Milestone Pharmaceuticals Announces Proposed Public Offering of Common Shares
    Milestone Pharmaceuticals Announces Proposed Public Offering of Common Shares

    https://www.globenewswire.com//news-release/2024/02/28/2837491/0/en/Milestone-Pharmaceuticals-Announces-Proposed-Public-Offering-of-Common-Shares-and-Pre-Funded-Warrants.html

    GLOBENEWSWIRE
    28 Feb 2024
    Share Share
    Milestone Pharmaceuticals Announces Plan to Resubmit NDA for Etripamil
    Milestone Pharmaceuticals Announces Plan to Resubmit NDA for Etripamil

    https://www.globenewswire.com//news-release/2024/02/26/2835011/0/en/Milestone-Pharmaceuticals-Announces-Plan-to-Resubmit-NDA-for-Etripamil-for-the-Treatment-of-PSVT.html

    GLOBENEWSWIRE
    26 Feb 2024
    Share Share
    Milestone Pharma Receives Refusal to File Letter from FDA for NDA for Etripamil
    Milestone Pharma Receives Refusal to File Letter from FDA for NDA for Etripamil

    https://www.globenewswire.com/news-release/2023/12/26/2801045/0/en/Milestone-Pharmaceuticals-Receives-Refusal-to-File-Letter-from-U-S-FDA-for-New-Drug-Application-for-Etripamil-in-the-Treatment-of-PSVT.html

    GLOBENEWSWIRE
    26 Dec 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search